Megabios is a leader in the field of gene therapy. It develops proprietary gene-based delivery systems and provides development expertise to create gene-based therapeutics for the treatment or prevention of genetic and acquired diseases. This year’s annual report focuses on the company’s strong base platform technology and, through the use of color and simple diagrams, explains the use of genes as therapeutics and their enormous potential.